Other

Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss

HCA Healthcare Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss decreased by 1.5% to $338.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $372.00M to $338.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2022
Last reportedQ1 2026Apr 29, 2026
Metric ID: other_debt_securities_available_for_sale_amortized_cost__4a59ca

Historical Data

13 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$411.00M$413.00M$410.00M$415.00M$413.00M$404.00M$402.00M$397.00M$396.00M$372.00M$349.00M$343.00M$338.00M
QoQ Change+0.5%-0.7%+1.2%-0.5%-2.2%-0.5%-1.2%-0.3%-6.1%-6.2%-1.7%-1.5%
YoY Change+1.0%+0.0%-1.5%-3.1%-3.9%-2.0%-7.5%-12.1%-13.4%-9.1%
Range$338.00M$415.00M
CAGR-6.3%
Avg YoY Growth-5.2%
Median YoY Growth-3.5%
Current Streak9 quarters decline

Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss at Other Companies

Frequently Asked Questions

What is HCA Healthcare's debt securities, available-for-sale, amortized cost, after allowance for credit loss?
HCA Healthcare (HCA) reported debt securities, available-for-sale, amortized cost, after allowance for credit loss of $338.00M in Q1 2026.
How has HCA Healthcare's debt securities, available-for-sale, amortized cost, after allowance for credit loss changed year-over-year?
HCA Healthcare's debt securities, available-for-sale, amortized cost, after allowance for credit loss decreased by 9.1% year-over-year, from $372.00M to $338.00M.